Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral Corticosteroids. (2017)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.clgc.2017.05.012
PubMed Identifier: 28606735
Publication URI: http://europepmc.org/abstract/MED/28606735
Type: Journal Article/Review
Volume: 15
Parent Publication: Clinical genitourinary cancer
Issue: 6
ISSN: 1558-7673